FeesSafety
Pluang+

Immunic appoints Jaa Roberson as Chief People Officer to strengthen leadership ahead of Phase 3 MS trial data.

Market News
19 Oct 2026, 13:30 WIB
PRNewsWire
View Source
Bullish
Immunic appoints Jaa Roberson as Chief People Officer to strengthen leadership ahead of Phase 3 MS trial data.

Immunic, a late-stage biotech company focused on neurologic diseases, has appointed Jaa Roberson as Chief People Officer to lead global talent and organizational strategy. This move supports Immunic's goal to build a strong multiple sclerosis (MS) organization ahead of pivotal Phase 3 trial results expected by the end of 2026 and potential commercialization of its drug vidofludimus calcium. Roberson brings over 20 years of HR experience in biopharma and will help scale the company from research to a fully integrated commercial entity. The appointment aligns with Immunic's preparation for regulatory filings and expanding its MS-focused team.

Immunic's leadership change is noted here with Pluang's Health sector data for context. As of Oct 19, 2026 17:11 WIB, 69 of 150 Health-sector US stocks on Pluang rose, 45 fell. Notable movers include AMRX at USD 19.55 (+1.93%), RLAY at USD 16.59 (+1.90%), and ERAS at USD 13.63 (+1.79%).

More News

Invesco Dorsey Wright Healthcare Momentum ETF rated Hold due to mixed performance and portfolio risks

Invesco Dorsey Wright Healthcare Momentum ETF rated Hold due to mixed performance and portfolio risks

The Invesco Dorsey Wright Healthcare Momentum ETF (PTH) receives a Hold rating due to its biotechnology-heavy portfolio showing mixed results. While it has strong quantitative and Wall Street ratings that might help it outperform broader healthcare E...

Analyst Insights
Bearish
5 hours ago
Nvidia shareholders urge careful CEO search, leaving door open for Jensen Huang's return after his resignation.

Nvidia shareholders urge careful CEO search, leaving door open for Jensen Huang's return after his resignation.

Two major Nvidia shareholders, Altimeter Capital and Atreides Management, have called on Nvidia's board to conduct a slow and deliberate CEO search that includes the possibility of Jensen Huang returning. Huang resigned as CEO amid an investigation i...

Market News
Bearish
5 hours ago
Savara (SVRA) rated speculative BUY ahead of key FDA decision on Nov 22 with $7 price target.

Savara (SVRA) rated speculative BUY ahead of key FDA decision on Nov 22 with $7 price target.

Savara (SVRA) is rated a speculative BUY at $4.72 with a $7 twelve-month price target, anticipating a crucial FDA decision on November 22 regarding its drug molgramostim. The company shows strong clinical efficacy data in Phase 3 trials, but faces si...

Market News
Bullish
5 hours ago
XRP falls below $1, losing 5th place in market cap amid ETF outflows and market sell-off

XRP falls below $1, losing 5th place in market cap amid ETF outflows and market sell-off

XRP dropped to $0.96, falling out of the top 5 cryptocurrencies by market value, now ranking sixth behind USDC. The coin has lost 26% since November 5, driven by a broader crypto market sell-off and no new inflows into US XRP ETFs since late October....

Market News
Bearish
5 hours ago
Bitcoin falls below its 200-week moving average amid $1.2B liquidations and ETF outflows

Bitcoin falls below its 200-week moving average amid $1.2B liquidations and ETF outflows

Bitcoin dropped below its 200-week moving average to around $65,700, marking the lowest level since August 2026. This decline was driven by over $1.2 billion in liquidations, mostly from long positions, and a seventh consecutive day of outflows from ...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App